Karyopharm Therapeutics Inc.
KPTIQ· OTC
Released Aug 10, 2015, before the open
10-Q filed Aug 10, 2015, 41 days after period end · 0001193125-15-283822
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2015 | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|---|
| Revenue | $150.00K | $21.00K | $133.00K | $533.00K |
| Net Income | -$32.70M | -$16.43M | — | — |
| EPS Diluted | -$0.92 |
Karyopharm Therapeutics Inc. · CIK 1503802 · Engraved from SEC EDGAR
| -$0.55 |
| -$2.86 |
| -$2.37 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.